<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: neurologists</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Neurologists Investigate Possible New Underlying Cause of MS</title>
   	 <description>(PhysOrg.com) -- Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).  The researchers will test the possibility that the symptoms of MS result from narrowing of the primary veins outside the skull, a condition called "chronic cerebrospinal venous insufficiency," or CCSVI.</description>
     <link>http://www.physorg.com/news174760709.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 14 Oct 2009 17:39:06 EST</pubDate>
	 <guid isPermaLink="false">news174760709</guid>
</item>
<item>
     <title>Parkinson's disease treatment strategies appear to have similar long-term effects on disability</title>
   	 <description>Patients with early Parkinson disease appear to have similar overall levels of disability and quality of life six years after beginning treatment with either levodopa or a dopamine agonist, according to a report posted online today that will appear in the May print issue of Archives of Neurology. However, persistent differences are seen in some effects of these medications, including motor symptoms, fluid build-up and sleepiness.</description>
     <link>http://www.physorg.com/news155842969.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 09 Mar 2009 18:43:29 EST</pubDate>
	 <guid isPermaLink="false">news155842969</guid>
</item>
<item>
     <title>Deep brain stimulation treatment for advanced Parkinson's disease patients provides benefits</title>
   	 <description>Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.</description>
     <link>http://www.physorg.com/news150483770.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 06 Jan 2009 17:02:50 EST</pubDate>
	 <guid isPermaLink="false">news150483770</guid>
</item>


</channel>
</rss>

